A biocidal product that comprises only approved active substances of the lists of Annex 1 or/and 2 of the OBP, can be authorised by a first authorisation in Switzerland (Authorisation AL) or another EU or EFTA Member State.
With the new procedure for the Union authorisation the European Biocidal Products Regulation (BPR)1 makes it possible for a biocidal product to be authorised for the entire EEA Market (plus Switzerland)2, thereby obviating the need for an application in the individual states for national authorisations or recognition.
The concept of the biocidal product family represents a further development of the concept of frame formulations. Under certain conditions, an authorisation as a biocidal product family is more flexible and enables a plurality of products to be brought to the market by means of a single authorisation.
An application for extension of a national authorisation (AL) – also known as a first authorisation, or a reference authorisation – or Union authorisation should be submitted to the national authority that assessed the first application. The application for extension must be submitted via R4BP at least 550 days prior to the expiration of the authorisation.